7.74

3.31% -0.265

Mind Medicine Inc (MNMD)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Mind Medicine Inc stock is currently priced at $7.74, with a 24-hour trading volume of 614.13K. It has seen a -3.31% decreased in the last 24 hours and a -8.83% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $7.99 pivot point. If it approaches the $7.72 support level, significant changes may occur.

Previous Close:

$8.005

Open:

24h Volume:

614.13K

Market Cap:

$556.29M

Revenue:

$11.40B

Net Income/Loss:

$-95.73M

P/E Ratio:

-3.8894

EPS:

-1.99

Net Cash Flow:

$-64.37M

1W Performance:

+6.76%

1M Performance:

-8.83%

6M Performance:

+115.00%

1Y Performance:

+113.81%

1D Range:

$7.70

$8.13

52W Range:

$2.41

$12.22

Mind Medicine Inc Stock (MNMD) Company Profile

Name

Mind Medicine Inc

Sector

Healthcare (1204)

Industry

Biotechnology (696)

Phone

Address

One World Trade Center, Suite 8500, New York

Employee

Twitter

Next Earnings Date

2024-06-10

Latest SEC Filings

MNMD's Discussions on Twitter

Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-22	Resumed	ROTH Capital	Buy
Nov-16-22	Initiated	RBC Capital Mkts	Outperform
Aug-26-22	Initiated	Oppenheimer	Outperform
Aug-10-22	Initiated	Cantor Fitzgerald	Overweight
May-04-22	Initiated	ROTH Capital	Buy
Jun-28-21	Initiated	Maxim Group	Buy

View All

Mind Medicine Inc Stock (MNMD) Latest News

Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - Yahoo Finance Australia

Yahoo Finance Australia

Mind Medicine Inc [MNMD] Records 200-Day SMA of $5.50 – Knox Daily - Knox Daily

Knox Daily

7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money

U.S News & World Report Money

7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money

U.S News & World Report Money

Robert W. Baird analysts initates an Outperform rating for Mind Medicine Inc (MNMD) – Knox Daily - Knox Daily

Knox Daily

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - MarketBeat

MarketBeat

Mind Medicine Inc Stock (MNMD) Financials Data

Mind Medicine Inc (MNMD) Revenue 2024

MNMD reported a revenue (TTM) of $11.40 billion for the quarter ending December 31, 2023, a +3.49% rise year-over-year.

Mind Medicine Inc (MNMD) Net Income 2024

MNMD net income (TTM) was -$95.73 million for the quarter ending December 31, 2023, a -68.55% decrease year-over-year.

Mind Medicine Inc (MNMD) Cash Flow 2024

MNMD recorded a free cash flow (TTM) of -$64.36 million for the quarter ending December 31, 2023, a -28.37% decrease year-over-year.

Mind Medicine Inc (MNMD) Earnings per Share 2024

MNMD earnings per share (TTM) was -$2.45 for the quarter ending December 31, 2023, a -33.15% decline year-over-year.

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.